In-silico Drug Repurposing for Targeting SARS-CoV-2 Main Protease (M)

Overview

Journal J Biomol Struct Dyn

Specialties Biochemistry
Molecular Biology

Date 2020 Nov 12

PMID 33179568

Citations 22

Authors

Shilpa Sharma

Shashank Deep

Affiliations

Soon will be listed here.

Abstract

COVID-19, caused by novel coronavirus or SARS-CoV-2, is a viral disease which has infected millions worldwide. Considering the urgent need of the drug for fighting against this infectious disease, we have performed in-silico drug repurposing followed by molecular dynamics (MD) simulation and MM-GBSA calculation. The main protease (M) is one of the best-characterized drug targets among coronaviruses, therefore, this was screened for already known FDA approved drugs and some natural compounds. Comparison of docking and MD simulation results of complexes of drugs with that of inhibitor N3 (experimentally obtained) suggests EGCG, withaferin, dolutegravir, artesunate as potential inhibitors of the main protease (M). Further, in silico docking and MD simulation suggest that EGCG analogues ZINC21992196 and ZINC 169337541 may act as a better inhibitor.Communicated by Ramaswamy H. Sarma.

Citing Articles

COVID-19-Induced Diabetes Mellitus: Comprehensive Cellular and Molecular Mechanistic Insights.

Nhau P, Gamede M, Sibiya N Pathophysiology. 2024; 31(2):197-209.

PMID: 38651404 PMC: 11036300. DOI: 10.3390/pathophysiology31020016.

Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive Review.

Al-Jamal H, Idriss S, Roufayel R, Khattar Z, Fajloun Z, Sabatier J Viruses. 2024; 16(3).

PMID: 38543686 PMC: 10974729. DOI: 10.3390/v16030320.

Screening of Multitarget-Directed Natural Compounds as Drug Candidates for Alzheimer's Disease Using Techniques: Their Extraction and Validation.

Srivastava S, Sharma S, Deep S, Khare S ACS Omega. 2023; 8(41):38118-38129.

PMID: 37867692 PMC: 10586450. DOI: 10.1021/acsomega.3c04261.

Green Tea Consumption and the COVID-19 Omicron Pandemic Era: Pharmacology and Epidemiology.

Storozhuk M, Lee S, Lee J, Park J Life (Basel). 2023; 13(3).

PMID: 36984007 PMC: 10054848. DOI: 10.3390/life13030852.

Identification of allosteric inhibitor against AKT1 through structure-based virtual screening.

Karunakaran K, Muniyan R Mol Divers. 2022; 27(6):2803-2822.

PMID: 36522517 DOI: 10.1007/s11030-022-10582-7.

References

Onufriev A, Case D . Generalized Born Implicit Solvent Models for Biomolecules. Annu Rev Biophys. 2019; 48:275-296. PMC: 6645684. DOI: 10.1146/annurev-biophys-052118-115325. View

Shereen M, Khan S, Kazmi A, Bashir N, Siddique R . COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020; 24:91-98. PMC: 7113610. DOI: 10.1016/j.jare.2020.03.005. View

Adem S, Eyupoglu V, Ibrahim I, Sarfraz I, Rasul A, Ali M . Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M) inhibitors to unveil a hope against COVID-19. Comput Biol Med. 2022; 145:105452. PMC: 8957318. DOI: 10.1016/j.compbiomed.2022.105452. View

Nance C, Siwak E, Shearer W . Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy. J Allergy Clin Immunol. 2009; 123(2):459-65. PMC: 2665796. DOI: 10.1016/j.jaci.2008.12.024. View

Singh A, Singh A, Shaikh A, Singh R, Misra A . Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr. 2020; 14(3):241-246. PMC: 7102587. DOI: 10.1016/j.dsx.2020.03.011. View

. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-544. PMC: 7095448. DOI: 10.1038/s41564-020-0695-z. View

Laskowski R, Swindells M . LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011; 51(10):2778-86. DOI: 10.1021/ci200227u. View

Benelli R, Vene R, Bisacchi D, Garbisa S, Albini A . Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem. 2002; 383(1):101-5. DOI: 10.1515/BC.2002.010. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

10.

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S . PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2018; 47(D1):D1102-D1109. PMC: 6324075. DOI: 10.1093/nar/gky1033. View

11.

Lisewski A, Quiros J, Ng C, Adikesavan A, Miura K, Putluri N . Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate. Cell. 2014; 158(4):916-928. PMC: 4167585. DOI: 10.1016/j.cell.2014.07.011. View

12.

Santos M, Moreira R . Michael acceptors as cysteine protease inhibitors. Mini Rev Med Chem. 2007; 7(10):1040-50. DOI: 10.2174/138955707782110105. View

13.

Cai Z, Zhang G, Tang B, Liu Y, Fu X, Zhang X . Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study. Cell Biochem Biophys. 2015; 72(3):727-39. DOI: 10.1007/s12013-015-0524-9. View

14.

Song J, Lee K, Seong B . Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005; 68(2):66-74. DOI: 10.1016/j.antiviral.2005.06.010. View

15.

Ho H, Cheng M, Weng S, Leu Y, Chiu D . Antiviral effect of epigallocatechin gallate on enterovirus 71. J Agric Food Chem. 2009; 57(14):6140-7. DOI: 10.1021/jf901128u. View

16.

Min S, Song I, Borland J, Chen S, Lou Y, Fujiwara T . Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers. Antimicrob Agents Chemother. 2009; 54(1):254-8. PMC: 2798521. DOI: 10.1128/AAC.00842-09. View

17.

Weber J, Ruzindana-Umunyana A, Imbeault L, Sircar S . Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res. 2003; 58(2):167-73. DOI: 10.1016/s0166-3542(02)00212-7. View

18.

Keiser M, Roth B, Armbruster B, Ernsberger P, Irwin J, Shoichet B . Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007; 25(2):197-206. DOI: 10.1038/nbt1284. View

19.

Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181(2):281-292.e6. PMC: 7102599. DOI: 10.1016/j.cell.2020.02.058. View

20.

Morris G, Huey R, Lindstrom W, Sanner M, Belew R, Goodsell D . AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(16):2785-91. PMC: 2760638. DOI: 10.1002/jcc.21256. View